Abstract:Diabetes mellitus (DM) is a major health issue globally. The incidence and prevalence of DM are increasing annually. DM as a serious, longstanding disorder displays a major influence on the quality of life and well-being of affected people, families, and societies all over the world. It is estimated to be one of the top 10 causes of death in adults. [ 1-3 ] Excess tissue glucose reacts with macromolecules such as nucleic acids, lipids, and proteins nonenzymatically, as a consequence, heterogeneous advanced glycation end products (AGE) would be produced. Thus, such irreversible alteration in macromolecule structures will impair their function. Although these reactions may occur under favorable conditions such as aging or smoking, serious oxidative stress disorders such as DM can accelerate tissue AGE accumulation. [ 4 ] Even in conditions of prepubertal diabetes, AGE was increased in association with hyperglycemia. [ 5 ] Specific AGE shows intrinsic fluorescence potency. Compared to plasma AGE, the measurement of skin autofluorescence (SAF) level by an AGE reader reflects tissue AGE more accurately. Accordingly, a strong relationship was found between SAF measurement and AGE accumulation by skin biopsy, glycated hemoglobin (HbA1c), or several diabetic complications. [ 6 ] Increased tissue AGE in body organs causes various pathologies that lead to organ dysfunction and complications. In our previous meta-analysis study, we obtained that higher SAF measurements were significantly associated with several diabetic complications, such as retinopathy, nephropathy, and neuropathy. [ 3 ] Similarly, a recent meta-analysis study demonstrated that SAF as a novel technology can successfully evaluate the risk of diabetic foot ulcers. [ 6 ] In addition, in a study, the authors suggested SAF measurement as a noninvasive technology for the detection of DM and individuals with impaired fasting glucose. [ 7 ] There are limited and discrete data comparing SAF levels in DM patients with nondiabetic individuals. Therefore, we aimed to design a systematic review and meta-analysis study of case-controls to validate tissue AGE measured by SAF in confirmed DM patients. This could be helpful to put a special concern on SAF level as a noninvasive, simple, and inexpensive method probably for earlier detection of DM cases or risk of DM complications and prevent them as possible.

The Association Between Skin Autofluorescence And Vascular Complications In Chinese Patients With Diabetic Foot Ulcer: An Observational Study Done In Shanghai

The Association Between Skin Autofluorescence and Vascular Complications in Chinese Patients With Diabetic Foot Ulcer

Elevated Skin Autofluorescence is Strongly Associated with Foot Ulcers in Patients with Diabetes: A Cross-Sectional, Observational Study of Chinese Subjects

An observational study of foot ulceration risk in diabetic patients evaluated with autofluorescence: 195 cases cross-sectional and one-year outcome

Accumulation of Advanced Glycation Endproducts and Subclinical Inflammation in Deep Tissues of Adult Patients with and Without Diabetes.

Associations between Skin Autofluorescence Levels with Cardiovascular Risk and Diabetes Complications in Patients with Type 2 Diabetes

Reference Values for the Chinese Population of Skin Autofluorescence As a Marker of Advanced Glycation End Products Accumulated in Tissue

Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis

Accumulation of Tissue Advanced Glycation End Products Correlated with Glucose Exposure Dose and Associated with Cardiovascular Morbidity in Patients on Peritoneal Dialysis

Cross-Sectional and Longitudinal Associations between Skin Autofluorescence and Tubular Injury Defined by Urinary Excretion of Liver-Type Fatty Acid-Binding Protein in People with Type 2 Diabetes

Skin Autofluorescence as a Potential Adjunctive Marker for Cardiovascular Risk Assessment in Type 2 Diabetes: A Systematic Review

Advanced glycation end products via skin autofluorescence as potential marker of carotid atherosclerosis in patients with type 2 diabetes

Is skin autofluorescence a novel non-invasive marker in diabetes? A systematic review and meta-analysis of case–control studies

Association between endothelial function and skin advanced glycation end-products (AGEs) accumulation in a sample of predominantly young and healthy adults

Correlative study of advanced glycation end products (AGE) and diabetic skin with microangiopathy

AGEs and chronic subclinical inflammation in diabetes: disorders of immune system.

Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population

Association of Advanced Glycation End Products with coronary Artery Calcification in Japanese Subjects with Type 2 Diabetes as Assessed by Skin Autofluorescence

Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study

Association between habitual dietary and lifestyle behaviours and skin autofluorescence (SAF), a marker of tissue accumulation of advanced glycation endproducts (AGEs), in healthy adults

Association Between Skin Autofluorescence and White Blood Cell Counts in Older Adults